Latest news
RNTX: Q3 net loss widened to $5.8M; positive LTI-03 data, but cash only funds operations into June 2025 - TradingViewTradingView · Sun, 09 Aug 2026 09:33:36 GMTRNTX: LTI-03 advances as a promising, safe IPF therapy with dual antifibrotic and regenerative action - TradingViewTradingView · Sun, 09 Aug 2026 09:16:18 GMTRNTX Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:31 GMT